Psychometric Properties of the International Trauma Interview (ITI) for ICD-11 PTSD and CPTSD

November 21, 2022 updated by: University of Zurich

The aim of the project is to evaluate the psychometric properties (e.g. validity, reliability) of the International Trauma Interview (ITI) - German version. The ITI is a structured clinical interview that corresponds to the ICD-11 criteria for diagnosing both posttraumatic stress disorder (PTSD) and complex posttraumatic stress disorder (CPTSD).

Eligible participants from psychiatric inpatient and outpatient facilities in Switzerland who have provided informed will complete various self-report measures about trauma-related mental health complaints. In addition, the ITI will be conducted by a trained clinician. Lastly, information from the medical chart will be further used for scientific purpose. The overall assessment will take approximately 1-2 hours to complete.

Study Overview

Study Type

Interventional

Enrollment (Actual)

77

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Zurich
      • Winterthur, Zurich, Switzerland, 8400
        • Integrierte Psychiatrie Winterthur, Spezialstation für Traumafolgestörungen

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 99 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Study-specific Inclusion criteria

  • Structured diagnostic procedures upon hospital entry not yet started, except for orienting assessments
  • Able to give informed consent as documented by signature
  • Able to understand and communicate in German Exclusion criteria
  • Clinical signs for impaired cognitive abilities
  • Other contraindications to undergo the clinical interview

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: International Trauma Interview (ITI)
The ITI consists of 18 items and for each symptom, standardized questions as well as probes are presented. A trained professional rates both symptom frequency and intensity, which are converted into an overall index of symptom severity. A diagnosis of PTSD/CPTSD is established by applying the ICD-11 diagnostic rules. It takes approximately 30-60 minutes to administer.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
International Trauma Interview (ITI)
Time Frame: Up to two weeks upon psychiatric ward entry
Up to two weeks upon psychiatric ward entry
Life Event Checklist DSM-5
Time Frame: Up to two weeks upon psychiatric ward entry
Up to two weeks upon psychiatric ward entry

Secondary Outcome Measures

Outcome Measure
Time Frame
Beck Depression Inventory II
Time Frame: Up to seven days upon psychiatric ward entry
Up to seven days upon psychiatric ward entry
Brief Symptom Checklist
Time Frame: Up to seven days upon psychiatric ward entry
Up to seven days upon psychiatric ward entry
Impact of Event Scale Revised Version
Time Frame: Up to seven days upon psychiatric ward entry
Up to seven days upon psychiatric ward entry
PTSD Checklist for DSM-5
Time Frame: Up to seven days upon psychiatric ward entry
Up to seven days upon psychiatric ward entry
Borderline Symptom List
Time Frame: Up to seven days upon psychiatric ward entry
Up to seven days upon psychiatric ward entry

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 2, 2020

Primary Completion (Actual)

October 15, 2021

Study Completion (Actual)

October 15, 2021

Study Registration Dates

First Submitted

September 9, 2019

First Submitted That Met QC Criteria

September 9, 2019

First Posted (Actual)

September 11, 2019

Study Record Updates

Last Update Posted (Actual)

November 22, 2022

Last Update Submitted That Met QC Criteria

November 21, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Post Traumatic Stress Disorder (PTSD)

3
Subscribe